• QT Medical CEO Dr. Ruey-Kang Chang Wins Digital Health Challenge Award at the Annual MedImmune California Translational Science Forum

    Mountain View, California, September 26, 2017 – QT Medical, the leader in ECG technology, has announced that its CEO, Dr. Ruey-Kang Chang, has been awarded the grand prize of Digital Health Challenge - a competition held by MedImmune. The competition was part of the Digital Health Transforming Drug Development Translational Science Forum, hosted annually by MedImmune, the global biologics research and development arm of AstraZeneca.

    Asthmagram -- a wearable patch for objective assessment of asthma symptoms and therapeutic controls of children with asthma, was presented and recognized by a panel of prominent industry funding experts and executives. As the Digital Health Challenge winner, Dr. Ruey-Kang Chang will receive a $20,000 cash prize along with the partnering opportunities with MedImmune and AstraZeneca.

    Competing under the idea of engaging in technologies to transform digital health, five finalists were selected from more than hundreds of companies, many of which are based in Silicon Valley and financed by venture capital. The companies were judged based on five selection criteria - Product, Technical Feasibility, Marketing/Strategy, Leadership Team, and Financial/Projection. The judges were Julia Belaya of Healthcare Innovation, Yan Cao of Diagnostics & Digital Health Catalyst, Alice Jacobs of Third Rock Ventures, Jane Osbourn of MedImmune, John Trainer of MedImmune, and Samuel Wu of Acuris Partners.

    About MedImmune

    MedImmune is an American biotechnology company focusing on infection, oncology, cardiovascular/gastrointestinal disease, neuroscience, respiratory disease and inflammation -- in the areas of products specializing for Asthma. MedImmune is a subsidiary of UK-based pharmaceutical giant AstraZeneca. For more information, visit MedImmune's website at

    To learn more about MedImmune Digital Health Transforming Drug Development Translational Science Forum and the Digital Health Challenge, visit and

  • And the 2nd runner-up of Asia Hardware Battle 2017 goes to…QT Medical!

    Shanghai, China, September 16, 2017 – QT Medical, Inc., a startup company specializing in the development and manufacturing of world's most compact 12-lead ECG system, along with two other startups, fifish and Youibot, have been honored at the Asia Hardware Battle 2017. Asia Hardware Battle is an annual competition run by TechNode with the goal to source the best uprising hardware stars in the region—South Korea, Japan, Israel, Singapore, Thailand, mainland China, Hong Kong, and Taiwan. QT Medical competed against fourteen other regional winners at the final global round under the main theme, mass innovation and entrepreneurship. Accredited industry leaders like Zhu Xiaohu (Managing Partner at GSR Ventures), Kuantai Yeh (Partner at Qiming Ventures), Grace Gu Minman (‎Principal at ZhenFund), and Markus Seidel (‎Vice President, Head of BMW Group Technology Office China) have all witnessed and honored QT medical a third-place award in recognition for its innovative and astounding solution.

    About TechNode

    TechNode is a leading international technology media platform in China. Started in 2009 by Dr. Lu Gang, TechNode began as one man’s attempt to tell the world about what’s happening in China’s tech and startup ecosystems. Since that time, we have grown into a trusted and respected information outlet, events organizer, and integral part of the tech and startup community both inside and outside of China with our partners at TechCrunch.

  • QT Medical Wins the 2017 TRANS Innovation Award

    Taipei, Taiwan, August 28, 2017 – QT Medical, Inc., a startup company specializing in the development and manufacturing of world's most compact 12-lead ECG system announces today that it has won the 2017 TRANS Innovation Award presented by TRANS 2017. The ceremony was on August 27th, at the TRANS Conference, an annual event that is curated by H. Spectrum and co-presented with YongLin Healthcare Foundation.

    The Award is organized alongside the TRANS Conference and exhibition each year from its inception in 2016 onwards, and rewards the best innovation in the designated theme every year. Industry veterans from start-ups, venture capital and industry giants, such as Google Verily, KPCB, GE Venture, gave their time and insights to speak individually and in panels. 60 international teams presented their developments and businesses within the two eventful days. QT Medical was crowned the winner as it addressed the defining theme, INNOVATION IN ASIA BETTER HEALTHCARE FOR ALL, with the new ECG technology that best improves the quality, efficacy, and cost-effectiveness of prevention, diagnosis, treatment, and care in health and medicine.

    About TRANS Conference and H.Spectrum

    H. Spectrum is a startup incubator focusing on the healthcare sector, supported by the YongLin Healthcare Foundation. The core vision is to boost the trend of healthcare startups and to groom the entrepreneur community in Taiwan.

    The TRANS conference is to provide a platform for healthcare startup founders and investors in Taipei to meet and connect in one of Asia’s industry hotspots.

    More information:

  • QT Medical has been selected in the Startup Global Program held by Garage +

    QT Medical has been selected in the Startup Global Program held by Garage + - a renowned non- profit organization not only provides space for incubation but also fosters a thriving startup ecosystem supported by experienced and successful entrepreneurs.

    There are 135 digital health startups from the world competing for only 20 seats and QT Medical is one of the top companies! QT Medical will join COMPUTEX with Garage + and will look forward to meeting you face-by-face at COMPUTEX to share the amazing technology in telemedicine field with you!


  • QT Medical is among 12 finalists entrepreneurship competition hosted by Tech Coast Angels

    QT Medical is among 12 Finalists competing for the Fast Pitch Competition in celebration of Entrepreneurship hosted by Tech Coast Angels-- the largest angel investor group in the US.

    via Tech Coast Angels' Celebration of Entrepreneurship

  • CEO of QT Medical, INC., Dr. Ruey-Kang Chang, will present at LA BioMed's 4th Annual Innovation Showcase

    CEO of QT Medical, INC., Dr. Ruey-Kang Chang, will present at LA BioMed's 4th Annual Innovation Showcase on Thursday, March 9, 2017 in Manhattan Beach, CA. The innovation Showcase brings together more than 300 participants from emerging life science companies and prestigious academic institutions across California to share knowledge and research about innovation in healthcare and discuss broader issues affecting the commercialization of new therapies.

    LA BioMed is one of the country's leading nonprofit independent biomedical research institutes committed to finding practical, inexpensive solutions to real-world health problems through biomedical discovery, fostering the researchers of tomorrow, and promoting wellness in every community.

    via LA BioMed Innovation Showcase 2017

  • Arab Health Exhibition and Congress 2017

    We had a great time during QT Medical's participation in the Arab Health Exhibition and Congress 2017!

    We had a great time during QT Medical's participation in the Arab Health Exhibition and Congress 2017! Visitors witnessed our success in bringing 12-lead ECG technology to another level and were impressed by our innovative R&D ability and adaptable market applications.

    QT Medical is now enthusiastically looking for global partners who are willing to share our challenges and and excitement while exploring the potential of new regions worldwide.

  • CEO Dr. Ruey-Kang Chang discussed screening young athletes with or without ECG in the Sports Cardiology Conference held by Children's Hospital Orange County

    Keynote Speaker:

    Ruey-Kang Chang, MD
    Professor in Residence of Pediatrics, David Geffen School of Medicine at UCLA
    Chief, Division of Pediatric Cardiology at Harbor-UCLA Medical Center

    Pediatric cardiologist Ruey-Kang Chang, M.D., M.P.H. has focused his research on public health issues related to infants and children with heart disease.

    Educated and trained in public health and clinically trained in pediatric cardiology, Dr. Chang is interested in looking at clinical problems from a public health perspective. His research has centered on the prevention of sudden death from silent or undiagnosed heart conditions. These include infants born with critical congenital heart disease that is not diagnosed in time for proper treatment; hypertrophic cardiomyopathy in competitive athletes; and Sudden Infant Death Syndrome (SIDS), which strikes some 2,500 families in the U.S. each year.

    Conference Overview:

    The conference will create an opportunity for all those involved in the care of athletes and young individuals in general to gain up to date education relating to the effects of athletic training and the diagnosis and management of individuals with inherited cardiac diseases, in the hope of preventing tragic young sudden deaths in the future.

    This biennial event attracts the world’s leading experts on sports cardiology and sudden cardiac death in the young.

    The aim of this conference is to draw together experts in the fields of sports cardiology, inherited cardiac diseases and sudden cardiac death in the young, who will present contemporary topics and developments in their respective fields.

    Date and time:

    Friday – January 20, 2017, 7:00 AM – 6:00 PM
    Saturday – January 21, 2017, 7:30 AM – 4:00 PM


    Disney’s Grand Californian Hotel
    1600 South Disneyland Drive Sequoia Ballroom
    Anaheim, CA 92808

    Sports Cardiology & Sudden Cardiac Arrest in the Young

  • 2016 Patrick Soon-Shiong Innovation Awards

    QT Medical has been named one of the 12 finalists from hundreds of nominations

    QT Medical has been named one of the 12 finalists from hundreds of nominations for the Los Angeles Business Journal’s 2016 Patrick Soon-Shiong Innovation Awards by the Los Angeles Business Journal.

    The awards are named for Dr. Patrick Soon-Shiong, a surgeon, entrepreneur and inventor who has pioneered therapies for diabetes and cancer and holds over 95 patents. It is a huge accomplishment for QT Medical for being a finalist at this year’s Patrick Soon-Shiong Innovation Awards.

    The award ceremony for the 2016 Patrick Soon-Shiong Innovation Awards will be at:

    Thursday, November 17, 2016
    8:00 AM – 11:00 AM Morning Symposium
    6:00 PM – 9:30 Awards Dinner
    Four Seasons Los Angeles at Beverly Hills
    300 South Doheny Drive
    Los Angeles, CA 90048